Market Performance - On January 6, A-shares saw all three major indices rise, with the Shanghai Composite Index increasing by 1.50% to 4083.67 points, marking a ten-year high [1] - The market's total trading volume exceeded 2.83 trillion yuan, an increase of over 260 billion yuan compared to the previous trading day, with more than 4100 stocks rising [1] - The Shanghai Composite Index recorded a 13-day consecutive rise, setting a historical record, surpassing the previous 12-day record held for 33 years [1] Sector Performance - The commercial aerospace sector continued to surge, with over ten constituent stocks hitting the daily limit, including Lushin Investment, which achieved six limit-ups in eight days [1] - The brain-computer interface concept maintained its strong performance, with stocks like Sanbo Brain Science and Meihao Medical achieving consecutive limit-ups [1] - The financial sector collectively rose, with Huayin Securities and Dazhihui hitting the daily limit [1] - The intelligent driving sector also showed strength, with multiple stocks like Wanjitech and Luchang Technology hitting the daily limit [1] - The chemical sector saw gains, with stocks such as Zhongtai Chemical and Luhua Technology hitting the daily limit [1] - The non-ferrous metals sector was active, with companies like Luoyang Molybdenum and Zijin Mining reaching historical highs [1] Market Outlook - Factors supporting the current bull market remain unchanged, including policy support and a shift of household savings to the capital market, with increasing foreign investment interest in China's technological innovation [2] - Goldman Sachs has recommended overweighting Chinese stocks for 2026, predicting a 15% to 20% annual increase in the Chinese stock market for 2026 and 2027 due to significant valuation discounts compared to global peers [2] - The market is expected to transition from a cross-year trend to a spring offensive, with increased credit issuance in January likely to bring additional funds into the capital market [3] - The overall sentiment suggests that 2026 will be a year of significant opportunities, with expectations of improved market performance and investor sentiment [3] Policy Environment - Future policies may include more proactive fiscal measures and moderately loose monetary policies, with the Federal Reserve expected to continue its rate-cutting cycle, creating favorable conditions for China's central bank [5] - In a declining interest rate environment, equity assets are likely to perform well, and the renminbi is expected to appreciate, attracting more foreign capital into Chinese assets [5] Investor Sentiment - The spring offensive has begun, and investors are encouraged to maintain confidence and patience, focusing on quality stocks or funds to capitalize on the slow bull market opportunities [6] - The number of new A-share accounts has continued to rise, reflecting the market's vitality, with 27.44 million new accounts opened in 2025, a 9.75% increase from 2024 [6]

Market Overview - The A-share market showed a strong performance with the Shanghai Composite Index approaching 4100 points, while the ChiNext Index and Shenzhen Component Index rose by 0.41% and 0.35% respectively, with a total trading volume of 1.85 trillion yuan, an increase of 538 billion yuan compared to the previous trading day [1] Semiconductor Sector - The semiconductor index rose by 2.20%, reaching 8181.14 points, with notable stocks such as ChipSource Microelectronics and Nanda Optoelectronics both increasing by 20% [2][3] Brain-Computer Interface Sector - The brain-computer interface sector continued to perform strongly, with companies like Innovation Medical and Nanjing Panda achieving three consecutive trading limit ups. Strong Brain Technology completed approximately 2 billion yuan in financing, marking it as the second-largest financing in the brain-computer interface field after Neuralink [4] Hong Kong Market - The Hong Kong market saw declines, with the Hang Seng Index and Hang Seng China Enterprises Index both dropping nearly 1%. Alibaba fell by nearly 4%, while companies like WuXi AppTec and China Life rose over 3% [5] Precious Metals Market - International precious metals experienced a downturn, with spot gold dropping below 4480 USD per ounce, while spot silver saw a slight decrease but maintained a year-to-date increase of 13% [6] Base Metals Market - The base metals market showed a strong performance, with SHFE nickel rising nearly 8% and SHFE tin increasing by nearly 6%. The LME copper reached a record high, driven by supply concerns [7]

【午评：沪指涨0.29%逼近4100点 两市半日成交1.84万亿】智通财经1月7日电，早盘沪指震荡拉升，创 业板指冲高回落。沪深两市半日成交额1.84万亿，较上个交易日放量538亿。盘面上热点快速轮动，光 刻胶概念爆发，国风新材3天2板，南大光电、彤程新材等多股涨停。可控核聚变概念表现活跃，王子新 材4天3板，中国一重、中国核建、国机重装涨停。脑机接口概念延续强势，创新医疗、南京熊猫双双3 连板。半导体设备股反复活跃，中微公司、北方华创大涨续创历史新高。电网设备股震荡走强，三变科 技、中国西电涨停。下跌方面，油气股表现较弱，中国海油下挫。截至收盘，沪指涨0.29%，深成指涨 0.35%，创业板指涨0.41%。 转自：智通财经 ...

Market Overview - The A-share market opened high on January 7, with the Shanghai Composite Index rising by 0.29% to 4095.54 points, the Shenzhen Component Index up by 0.35% to 14071.35 points, and the ChiNext Index increasing by 0.41% to 3332.74 points, marking a four-year high [1] - The total trading volume in the Shanghai and Shenzhen markets reached 1.84 trillion yuan, an increase of 53.8 billion yuan compared to the previous trading day [1] Sector Performance - The photolithography concept stocks surged, with Guofeng New Materials hitting the limit up for two consecutive days, and several other stocks like Nanda Optoelectronics and Tongcheng New Materials also reaching the limit up [1] - The controllable nuclear fusion concept showed strong performance, with stocks like Wangzi New Materials and China First Heavy Industries hitting the limit up [1] - The brain-computer interface concept continued its strong trend, with stocks such as Innovation Medical and Nanjing Panda achieving three consecutive limit ups [1] - Semiconductor equipment stocks were actively traded, with stocks like Chip Source Microelectronics and Hengkun New Materials hitting the limit up by 20% [1] - The electric grid equipment sector showed strength, with Sanbian Technology and China West Electric reaching the limit up [1] - In contrast, oil and gas stocks performed poorly, with China National Offshore Oil Corporation experiencing a decline [1] Hot Sectors - The storage chip concept was strong, with stocks like Yingxin Development achieving two consecutive limit ups, and others like Puran Shares and Jiangbolong also rising [2] - The nickel concept stocks saw a rally, with stocks like Greeenmei hitting the limit up, supported by a significant increase in nickel prices [3] - The controllable nuclear fusion concept stocks rose, with breakthroughs in experimental methods reported, indicating long-term growth potential for the industry [4] Institutional Insights - Huaxi Securities noted that the spring market rally has started early, maintaining a bullish outlook, and suggested focusing on emerging growth sectors and anti-involution opportunities [5] - Shenwan Hongyuan Securities emphasized that the spring market structure remains unchanged, with high elasticity in thematic opportunities, particularly in AI and cyclical sectors [5] - Dongfang Securities indicated that the Shanghai Composite Index is approaching the 4100-point mark, predicting a slowdown in upward momentum and potential volatility [6]

盘面上热点快速轮动， 光刻胶概念爆发， 国风新材3天2板，南大光电、彤程新材等多股涨停。可控核聚变概念表现活跃，王子新材4天3 板，中国一重、中国核建、国机重装涨停。脑机接口概念延续强势，创新医疗、南京熊猫双双3连板。 半导体设备股反复活跃， 中微公 司、北方华创大涨续创历史新高。电网设备股震荡走强，三变科技、中国西电涨停。 下跌方面，油气股表现较弱，中国海油下挫。截至收盘，沪指涨0.29%，深成指涨0.35%，创业板指涨0.41%。 下载财联社APP获取更多资讯 准确 快速 权威 专业 今日早盘， 沪指震荡拉升 逼近4100点， 创业板指冲高回落。沪深两市半日成交额1.84万亿，较上个交易日放量538亿。 7x24h电报 头条新闻 VIP资讯 实时盯盘 ...

凤凰网财经讯 1月7日，早盘沪指震荡拉升，创业板指冲高回落。截至午间收盘，沪指涨0.29%，深成指 涨0.35%，创业板指涨0.41%。沪深两市半日成交额1.84万亿，较上个交易日放量538亿。 | | | | | 沪深京重要指数 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 名称 *● | 最新 | 涨幅% | | 涨跌 | 息手 | 现手 | 金额 | | 上证指数 | 4095.54 | 0.29 | 11.87 | 1168/1088 | -0.04 4.32 乙 | 3.01万 7617.22亿 | | | 深证成指 | 14071.35 | 0.35 | 48.80 | 1234/1610 | -0.05 5.92 7. | 1619 1.07万亿 | | | 北证50 | 1506.61 | 0.91 | 13.57 | 153/121 | 0.01 682万 | 1324 186.83 Z | | | 创业板指 | 3332.74 | 0.41 | 13.45 | 635/732 | -0.08 1.79 7. | 16 ...

Core Insights - The brain-computer interface (BCI) sector is experiencing significant growth, highlighted by the recent completion of approximately 2 billion yuan financing by Qiangnao Technology, marking it as the second-largest financing in the field globally, after Neuralink [1][2] Industry Overview - The BCI sector has become the hottest investment track in the A-share market since the beginning of 2026, with multiple stocks such as Innovation Medical, Aipeng Medical, and Xiangyu Medical achieving consecutive trading limits [1] - The industry is currently driven by both policy support and technological breakthroughs, with expectations for Neuralink's large-scale production and automated surgical solutions marking a transition from clinical validation to commercial viability [3] Company Highlights - Qiangnao Technology, founded in February 2015, focuses on non-invasive BCI technology and has received FDA and CE certifications, making it one of the largest investors in BCI R&D globally [2] - The company has launched several products, including smart bionic limbs and brain-machine intelligent sleep devices, and has been recognized by TIME magazine as one of the best inventions of the year [2] Recent Developments - On January 6, multiple BCI stocks, including Sanbo Brain Science and Maillande, issued announcements regarding abnormal trading fluctuations, warning investors of potential risks [4][5][6] - Sanbo Brain Science, while experiencing significant stock price increases, clarified that it does not engage in BCI product development, and its revenue from neuro-regulation technology is minimal [4] - Maillande and Xiangyu Medical also reported that their BCI products are still in the R&D phase and have not yet achieved significant sales impact [5][6]

Group 1 - The brain-computer interface sector opened high again, indicating strong investor interest and market momentum [1] - Companies such as Beiyikang and Meihao Medical reached new highs, reflecting positive performance and growth potential [1] - Innovative Medical, Nanjing Panda, and Yanshan Technology achieved three consecutive trading limit ups, showcasing significant market enthusiasm [1] Group 2 - Sanbo Brain Science and Daoshi Technology also experienced upward movement, indicating a broader trend of growth within the sector [1]

Core Viewpoint - The brain-computer interface (BCI) sector is experiencing significant growth and investment, highlighted by the recent 2 billion yuan financing of Qiangnao Technology, marking it as the second-largest financing in the field after Neuralink [3][4]. Group 1: Investment and Market Dynamics - Qiangnao Technology, part of the "Hangzhou Six Little Dragons," has completed approximately 2 billion yuan in financing, positioning itself as a major player in the BCI market [3][4]. - The BCI sector has become the hottest investment track in A-shares since the beginning of 2026, with multiple stocks like Innovation Medical, Aipeng Medical, and Xiangyu Medical achieving consecutive trading limit increases [3]. - The market is witnessing a surge in interest, with several BCI-related stocks announcing abnormal trading fluctuations, prompting warnings about investment risks [7]. Group 2: Company Developments - Qiangnao Technology, founded in 2015, focuses on non-invasive BCI technology and has received FDA and CE certifications, making it one of the largest investors in BCI R&D globally [4][5]. - The company has launched several products, including smart bionic limbs and brain-machine sleep aids, and has been recognized by Time magazine as one of the best inventions of the year [4]. - Qiangnao's investor lineup includes prominent institutions such as IDG and various strategic partners, indicating strong market confidence [4]. Group 3: Industry Trends and Future Outlook - The BCI industry is in a high-growth phase driven by policy support and technological breakthroughs, with expectations for large-scale production and automated surgical solutions from companies like Neuralink [6]. - The transition from clinical validation to commercial scalability is underway, suggesting that BCI technology is moving towards becoming widely accessible products rather than just experimental tools [6]. - Companies like Xiangyu Medical and Weisi Medical are focusing on non-invasive BCI technologies, although they currently have limited revenue contributions from these products [8][9].

Core Insights - The report emphasizes the strong growth potential in the electronic materials sector, driven by rapid advancements in downstream industries, continuous technological iterations, and the backdrop of domestic substitution [2][6][10] - The mechanical equipment industry is expected to benefit from structural technological growth, particularly in high-end manufacturing, with a focus on sectors like controlled nuclear fusion and humanoid robots [12][14][17] Electronic Materials Sector - The semiconductor materials market is projected to reach $67.5 billion in sales by 2024, with a year-on-year growth of 3.8%, and is expected to exceed $87 billion by 2029, reflecting a CAGR of 4.5% from 2024 to 2029 [7] - The PCB materials segment is experiencing a shift towards high-frequency and high-speed applications, with the global market for electronic resins and fabrics estimated at approximately $33.02 billion and $24.13 billion respectively in 2023 [8] - The OLED materials market is anticipated to grow significantly, with global sales expected to reach $2.44 billion in 2024 and $8.498 billion by 2031, representing a CAGR of 19.8% from 2025 to 2031 [9] Mechanical Equipment Sector - The controlled nuclear fusion sector is entering a phase of accelerated commercialization, with significant government support and technological breakthroughs expected to drive growth [13][17] - The liquid cooling market is set to expand rapidly due to increasing demands for AI computing power, with liquid cooling becoming essential for future AI servers and data centers [14][17] - The humanoid robot industry is transitioning into mass production, with several companies achieving order and delivery milestones, indicating a growing market for related components [15][17] Tourism and Social Services - Domestic tourism showed strong growth during the New Year holiday, with 142 million domestic trips taken, reflecting a 5.2% increase year-on-year, and total spending reaching approximately 84.79 billion yuan, up 6.3% [20][22] - The cross-border travel market is also experiencing significant growth, with a 28.6% increase in the number of people entering and exiting the country during the holiday period [23] Medical and Biological Sector - The brain-computer interface market is gaining traction, with companies like Neuralink planning large-scale production of devices by 2026, indicating a growing interest in this emerging field [26][28][30] - Domestic companies are making strides in the brain-computer interface space, with over 200 firms reported to be involved, highlighting the potential for significant advancements in this technology [29][30]